1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid HemangioendotheliomaNeoplasms by Histologic Type, epithelioid hemangioendothelioma, hemangioendothelioma, hemangioma, neoplasm, vascular cancerRecruitingPhase 22026-05-26NCT07104331